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ABSTRACT
Dental pulp stem cells harbor great potential for tissue-engineering purposes. However, previous studies
have shown variable results, and some have reported only limited osteogenic and odontogenic potential.
Because bone morphogenetic proteins (BMPs) are well-established agents to induce bone and dentin forma-
tion, in this study STRO-1-selected rat dental pulp–derived stem cells were transfected with the adenoviral-
mediated human BMP-2 gene. Subsequently, the cells were evaluated for their odontogenic differentiation
ability in medium not containing dexamethasone or other stimuli. Cultures were investigated using light
microscopy and scanning electron microscopy (SEM) and evaluated for cell proliferation, alkaline phos-
phatase (ALP) activity, and calcium content. Real-time polymerase chain reaction (PCR) was performed for
gene expression of Alp, osteocalcin, collagen type I, bone sialoprotein, dentin sialophosphoprotein, and
dentin matrix acidic phosphoprotein 1. Finally, an oligo-microarray was used to profile the expression of
odontogenesis-related genes. Results of ALP activity, calcium content, and real-time PCR showed that only
BMP2-transfected cells had the ability to differentiate into the odontoblast phenotype and to produce a
calcified extracellular matrix. SEM and oligo-microarray confirmed these results. In contrast, the non-
transfected cells represented a less differentiated cell phenotype. Based on our results, we concluded that the
adenovirus can transfect STRO-1 selected cells with high efficacy. After BMP2 gene transfection, these cells
had the ability to differentiate into odontoblast phenotype, even without the addition of odontogenic sup-
plements to the medium.
INTRODUCTION
T ISSUE ENGINEERING REQUIRES THREE KEY ELEMENTS: mor-phogenetic signals, including growth and differen-
tiation factors; responding stem cells; and a biocompatible
scaffold.1 Stem cells have been isolated from many tissues,
including bone marrow, neural tissue, skin, fat, and muscle.
Currently, mesenchymal stem cells have also been found in
dental pulp tissue.2–4 Such dental pulp–derived adult stem
cells (DPSCs) have exhibited multilineage potential and were
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able to differentiate toward odontoblast-like cells, adipo-
cytes, myocytes, and neural cells.2–6 These cells were rela-
tively easy to expand in vitro, and could be passaged more
than 25 times.3 However, as a new stem cell source for tissue
engineering, the in vivo transplantation of such cells in po-
rous calcium phosphate, collagen, or titanium fiber mesh did
not show adequate hard-tissue formation.5,7 These results
suggest a hierarchy of progenitors in adult dental pulp, in-
cluding a minor population of self-renewing, highly prolif-
erative, multipotent stem cells, in a larger compartment of
probably more committed progenitors.5
For successful tissue-engineering strategies, stem cell
technology needs to be optimized. Previous studies have
already shown that dental pulp cells could be derived from
human or even rat biopsies using STRO-1 cell selec-
tion.4,6,8,9 STRO-1 is described as a marker of mesenchymal
stem and precursor cells,9,10 and selection with this marker
increases the ability of osteo- and odontogenic differentia-
tion, as well as development toward other differentiation
pathways.6,9–13
Another strategy to enhance the efficacy of stem cells
could be the addition of growth factors. Recombinant human
bone morphogenetic protein (BMP)-2 can stimulate differ-
entiation of dental pulp cells into odontoblasts.14 The os-
teoinductive potential of recombinant human BMP-2 has
also been confirmed in clinical studies.15 However, there are
some limitations for local delivery of BMP, including short
half-life, large dose requirement, high cost, the need for re-
peated applications, and poor distribution.16 Possibly, trans-
fer of the Bmp2 gene into DPSCs could solve this problem.
Recently, several studies have showed that adenoviral-
mediated BMP-2 (AdBMP-2)-transfected cells in bone im-
plants were capable of stable expression of BMP-2 and
revealed exciting results in ectopic osteoinduction animal
models.17 Furthermore, adenoviruses are well known for ef-
ficient delivery of therapeutic genes and have already been
applied to clinically relevant gene therapy.18
In this study, the differentiation characteristics of trans-
fected STRO-1-selected rat DPSCs with adenoviral-mediated
human Bmp2 gene were evaluated. We hypothesized that
Bmp2-transfected cells have greater odontogenic differentia-
tion potential than non-transfected cells, even when cultured
in medium without dexamethasone or other stimuli.
MATERIAL AND METHODS
Cell culture
STRO-1-selected rat DPSCs (10th passage) obtained
using fluorescence-activated cell sorting9 were expanded in
minimal essential medium alpha (a-MEM; GIBCO-BRL,
Breda, The Netherlands) supplemented with 10% fetal calf
serum (FCS; GIBCO-BRL) and gentamycin (50 mg/mL;
Sigma, St. Louis, MO). The multilineage potential of this
cell population was confirmed in a previous study.19
Adenovirus gene transfer
A replication-deficient adenoviral vector carrying the
human Bmp2 gene AdBMP-2 was used in the current study.
First, to acquire effective gene transfer, an optimum multi-
plicity of infection (MOI) was evaluated. Cells were seeded in
a 24-well plate with a density of 2104 cells/well. AdBMP-
2 was added to the cells with different MOIs (0, 5, 10, and
100). Forty-eight h after transfection, the presence of BMP-
2 in the culture supernatants was tested using a modified
BMP-selective reporter bioassay inducing luciferase expres-
sion. Luciferase activity was quantified using the Bright-
GloLuciferase Assay System (Promega, Madison, WI). For
the standard curve, serial dilutions of recombinant human
BMP-2 (rhBMP-2; R&D Systems, Abingdon, United King-
dom) were used. The lower detection limit of this assay was
1.6 ng/mL BMP-2.
Second, after achieving the optimum MOI, the cells were
plated at the same density in 24-well plates. Twenty-four h
after seeding, cells were infected with AdBMP-2 (dilution
in a-MEM) at the optimum MOI. The transfected and non-
transfected cells were cultured for 24 days in a-MEM-
supplemented 10% FCS and 50 mg/mL gentamycin. Culture
medium was changed at 3-day intervals.
Cell proliferation and alkaline phosphatase activity
One, 4, 8, 12, 16, and 24 days after gene transfer, the pro-
liferation rates of the cells, as measured according to total
deoxyribonucleic acid (DNA) content (n¼ 6 for each time
point), were assessed using a PicoGreen double strand DNA
quantification kit (Molecular Probes, Leiden, The Nether-
lands).4 One mL of Milli-Q water (Millipore, Billerica, MA)
was added to each well to lyse the cells. One hundred mL of
PicoGreen working solution was added to 100-mL superna-
tants of samples. After incubation, the fluorescence of each
sample was measured using a fluorescence microplate reader
(Bio-Tek Instruments Inc., Windoski, VT), with a 365-nm
excitation filter and a 450-nm emission filter, and the DNA
amounts were calculated from a standard curve.
The same supernatants as used for the PicoGreen assay
were used to measure cellular ALP activity (Sigma). Twenty
mL of 0.5-M 2-amino-2-methyl-1-propanol buffer was ad-
ded to 80 mL of the samples or standards. Next, 100 mL of
substrate solution (p-nitrophenyl phosphate) was added, and
the mixtures were incubated at 378C for 1 h. ALP activity
was measured at 405 nm using an enzyme-linked immuno-
sorbent assay microplate reader (Bio-Tek Instruments Inc.).
Calcium content
Four, 8, 12, 16, and 24 days after gene transfer, the rate
of calcified extracellular matrix (ECM) deposition was as-
sessed by measuring the calcium content of the samples
(n¼ 6) using an ortho-cresolphthalein complexone (OCPC,
Sigma) method. One mL of 1-M acetic acid was added to
each well overnight. Working solution was prepared; 5 mL of
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OCPC solution was added to 5 mL of 14.8 M ethanolamine-
boric acid buffer (pH 11), 2 mL of 8-hydroxyquinoline, and
88 mL of Milli-Q water. Ten mL of sample or standard was
added to 300mL of working solution. Serial dilutions of cal-
cium chloride were used to generate a standard curve. The
plate was incubated at room temperature for 10 min and then
read at 575 nm (Bio-Tek Instruments Inc.).
Scanning electron microscopy
Cells were cultured on coverslips (Thermanox; Miles
Laboratories Inc., Naperville, IL) (n¼ 2) and fixed in 2%
glutaraldehyde (5 min) 1, 8, and 16 days after gene transfer.
They were then dehydrated in graded series of ethanol, and
dried in tetramethylsilane (Merck, Darmstadt, Germany).
Gold was sputtered on the samples just before scanning
electron microscopy (SEM) analysis. The specimens were
examined using a Jeol 6310 scanning electron microscope
(JEOL Europe BV, Nieuw Vennep, The Netherlands).
Real-time quantitative polymerase chain reaction
On days 1, 4, 8, and 16 after gene transfer, total ribonu-
cleic acid (RNA) of every sample was isolated using the
RNEasy kit (Qiagen, Venlo, The Netherlands). Quantity and
quality of the RNA was measured using a spectrophotome-
ter (SmartSpecs Plus, Biorad Laboratories, Veenendaal, The
Netherlands). One mg of RNA was used to make comple-
mentary DNA (cDNA) using the reverse transcriptase poly-
merase chain reaction (PCR) method (Invitrogen, Breda,
The Netherlands). To perform quantitative PCR, a SYBR
Green PCR kit was used (Eurogentec, Liege, Belgium), and
reactions were controlled in a spectrofluorometric thermal
iCycler (Biorad, Richmond, CA). The odontogenic differ-
entiation was monitored according to six markers: ALP,
osteocalcin (OC), collagen type I (Col I), bone sialoprotein
(BSP), dentin sialophosphoprotein (DSPP), and dentin ma-
trix protein-1 (DMP-1). Glyceraldehyde-3-phosphate de-
hydrogenase (GAPDH) was used as a housekeeping gene to
normalize RNA expression (Table 1).
DNA was PCR-amplified under the following conditions:
2 min at 508C and 10 min at 958C, followed by 40 cycles of
15 s at 958C and 1 min at 608C, with data collection in the
last 30 s. After the real-time PCR run, a Ct-value showed
how many PCR cycles were necessary to obtain a certain
level of fluorescence. Amplification efficiency of different
genes was determined relative to GAPDH as an internal con-
trol (A¨Ct¼CtgeneCtGAPDH). Messenger RNA (mRNA)
in each sample was calculated using a comparative A¨A¨Ct
(A¨Ctgene A¨Ctcontrol) value method. The fold change in
gene expression relative to the control was calculated using
2A¨A¨CT.20 Each sample was assessed in triplicate.
Oligo microarray
RNA samples from days 0 and 8 were analyzed using the
Oligo GEArray Rat osteogenesis microarray (Cat. No. ORN-
026; SuperArray, Bioscience Corporation, Frederick, MD).
According to the instructions from the manufacturer, an
annealing mix was made with 1 mg of RNA to synthesize
cDNA. The Amplification Master mix was then added to
the cDNA synthesis mix and incubated overnight at 378C to
produce cRNA. After prehybridizing the array membrane
with the GEAhyb hybridization solution, 10 mg of cRNA in
750 ml of hybridization buffer was added to the membrane to
allow hybridization overnight at 608C. Afterward, the mem-
brane was blocked for 40 min using GEAblocking solution.
Subsequently, 2 mL alkaline phosphatase (AP)-streptavidin
(1:7500) was added to the membrane and incubated for
10 min. Finally, the membrane was incubated with 1 mL of
CDP-star chemiluminescence substrate at room temperature
for 5 min. Then, the membrane was exposed to an X-ray film
for detection. The images were analyzed using the GEArray
Expression Analysis Suite.
Statistical analysis
Statistical significance in this study was evaluated using
paired t testing. p< 0.05 was considered significant. Error
bars represent means standard deviations (SD).
RESULTS
Gene transfer and cell proliferation
The test for MOI showed that cells could be transfected
with BMP-2 adenovirus. After 48 h, the transfected cells se-
creted 4.3, 5.0, 34.5, and 101.9 ng/mL of rhBMP-2 at MOI
TABLE 1. THE RAT-SPECIFIC PRIMER SEQUENCES USED FOR REAL-TIME POLYMERASE CHAIN REACTION
Sense primer Antisense primer
Alp 50-GCTTCACGGCATCCATGAG-30 50-GAGGCATACGCCATGACGT-3
OC 50-GGCTTCCAGGACGCCTACA-3 50-CATGCCCTAAACGGTGGTG-30
Col I 50-TGGAATCTTGGATGGTTTGGA-30 50-GCTGTAAACGTGGAAGCAAGG-30
Dspp 50-CGGTCCCTCAGTTAGTC-30 50-TACGTCCTCGCGTTCT-30
Dmp1 50-CGTTCCTCTGGGGGCTGTCC-30 50-CCGGGATCATCGCTCTGCATC-30
Bsp 50-ACTTCCCTTCGCAAGCTTAGG-30 50-AAACTTCCCGCGTATGTTGG-30
Gapdh 50-GAAGGGCTCATGACCACAGT-30 50-GGATGCAGGGATGATGTTCT-3
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of 0, 10, 50, and 100, respectively. Therefore, in the main
study, cells were infected with AdBMP-2 at a MOI of 100.
After gene transfer, both populations showed exponential
growth for 24 days. Cells grew more rapidly in the non-
transfected group than in the transfected group ( p< 0.05)
(Fig. 1A).
ALP activity and calcium content
The transfected cells showed increasing ALP activity
until day 16. At day 24, the ALP activity decreased. The
transfected cells showed significantly higher levels of ALP
activity than non-transfected cells ( p< 0.01) (Fig. 1B). Fi-
nally, significantly higher levels of calcium were observed
at days 12, 16, and 24 for the transfected cells ( p< 0.01)
(Fig. 1C).
SEM analysis
One day after transfection, SEM analyses showed that all
cells had spread well on the surface of the coverslips. Most
of the cells had multiple filopodia, and nuclei and nucle-
oli could be observed clearly. There were no differences
between the 2 groups (Fig. 2A, B). Although no external
source of phosphate (no b-glycerophosphate) was added to
the cultures, a noticeable amount of mineralized ECM was
observed at day 16 in the cultures of transfected cells (Fig.
2C). In contrast, the control cells only formed a confluent
layer, without any obvious sign of mineralization (Fig. 2D).
Real-time quantitative PCR
Expression levels of mRNA for Alp, Col I, OC, Bsp,
Dspp, and Dmp1 were compared on days 1, 4, 8, and 16.
mRNA expression levels of cells before gene transfer (day 0)
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FIG. 1. Growth characteristics of transfected and non-transfected
cells cultured in non-osteogenic medium. (A) The Proliferation
characteristics, (B) ALP activity, and (C) Calcium content. The
bars represent means SD (n¼ 6). *p< 0.05, **p< 0.01.
FIG. 2. Scanning electron micrographs of 2 cell populations.
(A) Transfected cells on day 1, (B) non-transfected cells on day 1,
(C) transfected cells on day 16, (D) non-transfected cells on day 16.
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FIG. 3. Representative curves of the messenger ribonucleic acid levels of alkaline phosphatase (Alp) (A), collagen type I (Col 1)
(B)¼,; osteocalcin (OC) (C), bone sialoprotein (Bsp) (D), dentin sialophosphoprotein (Dspp) (E), and dentin matrix acidic phospho-
protein 1 (Dmp1) (F) quantified on day 16. Cells were from s cell fractions.
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were set as baseline control (relative expression value,
100%). Results showed that Alp was gradually up-regulated
in transfected cells approximately 0.46-, 2.1-, 7.8-, and 2.9-
fold on days 1, 4, 8, and 16 respectively. In contrast, non-
transfected cells showed no up- or down-regulation of Alp
on these days (Fig. 3A). Col I showed up-regulation for
the transfected cells only on day 4 (3-fold) (Fig. 3B). OC
showed some up-regulation on days 8 (7.4-fold), and 16
(24-fold) in transfected cells and minimal increase in non-
transfected cells (Fig. 3C). Bsp also revealed up-regulation
of transfected cells on days 4 (2.1-fold), 8 (3.9-fold), and 16
(2.7-fold) (Fig. 3D). The expression of Dspp and Dmp1,
two dentin-specific markers, showed similar profiles. They
were down-regulated on day 1 (0.19- and 0.26-fold, respec-
tively). On day 4, Dmp1 showed upregulation in transfected
cells, whereas Dspp showed no differences. On day 16, Dspp
and Dmp1, were up-regulated approximately 4.6- and 2.4-
fold, respectively (Fig. 3E, F).
Gene expression profiles in oligo-microarray
The Oligo GEArray Rat osteogenesis microarray profiled
the expression of 113 key genes involved in osteogenic dif-
ferentiation. This system was used to compare the multiple
gene expression profiles representative of the transfected
cells and non-transfected cells at day 8 with those of the con-
trol cells at day 0. Table 2 shows the up- or down-regulation
of the different functional genes. A 2-fold change (or more)
in signal density was defined as a relevant change in gene
expression level. Thirty-six functional genes that were up-
regulated in the transfected cells compared to non-transfected
cells (Table 3). For the down-regulated genes, this number
was 15. Several genes, belonging to the categories of tran-
scription factors and regulators, growth factors, ECM, and
cell proliferation (i.e. Twist2, Csf3, Fgf3, Col5a1, Itga2,
Smad4, and Vcam1), were down-regulated in the transfected
cells. The results showed that genes involved in skeletal de-
velopment, bone mineral metabolism, cell growth and dif-
ferentiation, ECM molecules, cell adhesion molecules, and
transcription factors and regulators were more up-regulated
in transfected cells than in control and non-transfected cells
(Table 2). In particular, bone gamma-carboxyglutamate
protein 2 (Bglap2); bone morphogenetic protein receptor,
type 1A (Bmpr1a), 1b, and 2; Biglycan; Anxa5; Bmp1 to 7;
Col4a1, Matrix Gla protein; Msh homeo box homolog 2
(Msx2); and ameloblastin showed higher up-regulation in
transfected cells than in non-transfected cells (Table 3).
DISCUSSION
Gene therapy has shown potential for dental tissue engi-
neering. In previous studies, Bmp7 and Bmp11 have been
applied in in vitro gene therapy and resulted in reparative
TABLE 2. FUNCTIONAL GENE EXPRESSION IN TRANSFECTED AND NON-TRANSFECTED CELLS ON DAY 8,
COMPARED WITH CONTROL CELLS ON DAY 0
Transfected Non-transfected
Major category Subcategory Up Down Up Down
Skeletal Bone mineralization 7 1
development Cartilage condensation 4 2 1
Ossification 9 2
Osteoclast differentiation 1 1 1
Other genes involved 7 2 1
Bone mineral metabolism Calcium ion binding and homeostasis 9 3 3
Phosphate transport 5 1 3
Cell growth Regulation of the cell cycle 5 1 5
and differentiation Cell proliferation 8 1 5
Growth factor and receptors 21 2 7 4
Cell differentiation 7 1 3
Extracellular matrix Basement membrane constituents 2 1
(ECM) molecules Collagens 1 1 1
ECM protease inhibitors 2
ECM proteases 5 1 3 1
Structural constituents of tooth enamel 2 1
Other ECM molecules 24 3 7 4
Cell adhesion molecules Cell-cell adhesion 1
Cell-matrix adhesion 1 1
Other cell adhesion molecules 5 1 2
Transcription factors
and regulators
Transcription factors and regulators 7 2 4
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dentin formation in vivo.21,22 However, no study has inves-
tigated the differentiation efficacy of Bmp2 gene transfected
dental pulp stem cells. The current study showed that STRO-
1-selected rat DPSCs could be transfected with AdBMP-2
and that the transfected cells secreted human BMP-2 in
high levels (*102 ng/mL) after 48 h. Evidently, BMP-2
accumulated in this study to a functional concentration to
induce cell differentiation in vitro.14,23,24 Although only the
BMP-2 protein expression at 48 h was tested, other studies
have showed that the adenovirus also has the ability to me-
diate high levels of gene expression in cells for incubation
times longer than 3 weeks.25
In our study set-up, we specifically chose cell-culturing
conditions without external addition of dexamethasone.
Stem cells cultured with dexamethasone before implanta-
tion have demonstrated greater bone formation but over a
shorter length of time. The result of culturing cells with os-
teogenic supplements may mask part of the benefit of BMP-
2 produced from our genetically modified cells.26
In our results, we first addressed proliferation character-
istics. Previous studies have indicated that an adenovirus
dose of 107 particle units or an MOI of more than 50 can
provoke a cytotoxic response to the infected cells.27,28 In our
study, the transfected cells showed exponential growth, al-
though there was a small delay for cell proliferation in the
early phase. This delay can be due to a hampering effect of
the transfection or the inverse relationship between prolif-
eration and differentiation. When cells are more prolifera-
tive, then the differentiation of the cells is slowed, and vice
versa.29
ALP is a prerequisite for the differentiation of dental pulp
in vivo. In our study, transfected DPSCs showed signifi-
cantly higher ALP activity rates than non-transfected cells,
which was analogous to that of cells under the influence of
a standard osteogenic medium.4 The real-time PCR results
confirmed the up-regulation of ALP expression. However,
the expression of mRNA always occurs before protein ex-
pression, and thus it is understandable that mRNA expres-
sion of ALP reached a peak on day 8, whereas ALP activity
in the biochemical assay showed a peak value on day 16.
Calcium content and SEM observation demonstrated more
calcified matrix deposition for transfected cells. The trans-
fected cells showed the ability to form multilayers and min-
eralized nodules on a smooth surface in vitro, even without
the addition of an external source of phosphate.
Collagen type I is the predominant protein and the basis
for dentin repair. Some noncollagenous proteins in dentin
and bone include OC and BSP. In addition, DSPP is the
major part of noncollagenous proteins in dentin and plays
a crucial role during dentin mineralization.30 DMP-1 is an-
other specific protein in dentin and is a candidate gene for
dentinogenesis imperfecta.31 Although the different genes
showed different mRNA expression profiles, gene expres-
sion was enhanced after AdBMP-2 transfection. This
change was comparable with that of DPSCs under osteo-
genic culture or treated with rhBMP-2 protein.2,4,14 The
expression of these markers offers strong evidence that
DPSCs differentiated into odontoblasts, because of the
presence of BMP-2 protein originating from the adenoviral-
mediated Bmp-2 transfer.
In two previous studies, representative gene expression
profiles and functional classifications of human DPSCs and
mesenchymal stem cells (MSCs) from bone marrow were
compared using a cDNA microarray system containing more
than 4,000 or 12,814 human genes.32,33 Human DPSCs and
MSCs were found to have similar levels of gene expres-
sion for more than 4,000 known genes. A few genes, includ-
ing Collagen type XVIII a1, insulin-like growth factor-2,
discordin domain tyrosine kinase 2, and cyclin-dependent
kinase 6, were more highly expressed in DPSCs.32 Further-
more, the studies revealed that, upon prolonged culturing,
each cell type regulates the expression levels for several
genes belonging to cell division, cell signalling, cell struc-
ture, and metabolism, differently.33 In the present study, the
results of the functional oligo-microarray for rat osteogen-
esis showed that the transfected cells had higher expression
levels of functional genes. These genes were divided into
several functional categories, including skeletal develop-
ment, bone mineral metabolism, cell growth and differ-
entiation, ECM molecules, cell adhesion molecules, and
transcription factors and regulators. The high expression
levels of Alp, Dspp, and Dmp1 in the transfected cells con-
firmed the PCR and ALP activity results of our study. Fur-
thermore, BMP-2, -4, -6, and -7, which are strong promoters
of osteogenesis, mineralization formation, and tooth mor-
phogenesis,17,34 showed markedly greater expression levels
than the non-transfected cells. The higher expression levels
for the BMP receptors (Bmpr1a, Bmpr1b, and Bmpr2) in
transfected cells are probably a logical result of the higher
levels of secreted BMP-2. Furthermore, the increase in
protein expression of BMP-2 results in signals from the
plasma membrane to the nucleus requiring several SMAD
proteins.35 This could explain the upregulation for Smad 1,
2, 3, and 7 in the transfected cells. In the present study, Msx2
was also up-regulated after transfection. This is noticeable
because Shi et al. described that DPSCs and BMSCs ex-
pressed Msx2 was at a low levels.36 The BMP–Msx path-
way mediates reciprocal interactions between the epithelium
and mesenchyme during early bone and tooth development.
BMP-4 is known to induce Msx2 expression in cultured
dental mesenchyme.37
Two final genes that were interestingly up-regulated were
Bglap2 and Ambn.Bglap2, encoding a highly conserved pro-
tein associated with mineralized bone matrix and secreted by
calcified tissues, was highly expressed in transfected cells,
and Ambn encodes ameloblastin, which acts as a structural
component of tooth enamel matrix.35 This gene manifested
up-regulation only in transfected cells. Generally, more ac-
tive odontogenesis-related genes were undoubtedly found in
the transfected cells, meaning that these cells were more
2810 YANG ET AL.
directed toward the odontogenic pathway.
In summary, rat STRO-1-selected dental pulp stem cells
were successfully transfected with AdBMP-2. Transfected
cells underwent more effective induction toward the odon-
toblast phenotype than non-transfected cells, even in me-
dium without externally added substitutes (dexamethasone,
b-glycerophosphate). The results of this study were in accor-
dance with our hypothesis, and the combination of a more
homogeneous cell population with gene transfection could
be a strategy to improve the clinical efficacy of DPSCs for
hard tissue engineering. To prove that presence of BMP is a
denominator for odontogenic differentiation, and thus to rec-
oncile previous discordant reports, animal studies are nec-
essary. Therefore, further evaluation should be performed in
3-dimensional scaffolds in vitro and in vivo.
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